| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e5de466eb38d001df59e40e653636c1 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-104
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-21 |
| filingDate |
2006-08-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e6ea8307193c85d680402826612430f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_576343860b53f182b6a0b73646a26361 |
| publicationDate |
2008-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-101243104-A |
| titleOfInvention |
Interaction of moraxella catarrhalis with epithelial cells, extracellular matrix proteins and the complement system |
| abstract |
The present invention relates to extracellular matrix proteins of Moraxella catarrhalis and their ability to interact with epithelial cells via cellassociated fibronectin and laminin, and also to their ability to inhibit the complement system. These extracellular proteins are useful in the preparation of vaccines. The present invention provides peptides interacting with the fibronectin, laminin and complement system. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105203754-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111499701-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106061995-A |
| priorityDate |
2005-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |